Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Biopharm Stat. 2017 Oct 30;28(4):633–644. doi: 10.1080/10543406.2017.1372773

Table 2.

Percentage of trials with z < −1.96 and z < −2.576, for 10,000 simulated trials with 300 patients in each arm, for each of 30 conditions, with respective experimental and control median survival times of 4.2 and 3 and with loss to follow-up (LTFU) for some control patients.

y is uniform (w = 1)
% rejection
(one-tailed)
at level of
y is triangular (w = 2)
% rejection
(one-tailed)
at level of
b, Weibull shape
parameter
Control patients,
LTFU parameter
0.025 0.005 0.025 0.005
0.8 0% 69.28% 45.24% 69.17% 44.63%
5 55.58 32.29 52.68 28.99
5 to 15 53.94 30.68 46.40 24.08
10 41.36 20.72 36.21 17.07
15 to 5 32.88 14.22 29.54 12.13
1 (exponential distribution) 0 87.50 69.60 87.41 69.59
5 79.25 58.00 77.08 54.59
5 to 15 78.57 56.35 71.44 48.22
10 67.31 44.22 62.35 38.14
15 to 5 60.71 36.41 57.01 32.24
1.25 0 97.38 91.49 97.86 91.16
5 95.25 85.54 94.36 83.30
5 to 15 94.62 83.87 91.70 78.22
10 91.20 76.97 87.93 71.44
15 to 5 87.19 69.60 84.47 65.29